Marvell vs. Broadcom: One Custom Chip Stock Wins.

Marvell (market cap ~ $90B) trades at ~26x forward EPS with analyst EPS growth forecasts of 35% for FY2027 and 42.2% for FY2028 (revenue growth ~33% → 37%), but is highly exposed to hyperscaler AI capex and cyclical hardware margins. Broadcom (market cap ~$1.48T) carries >$66B debt vs $14.2B cash after the VMware deal, trades at ~61x spot PE (sub-28x forward), and has analyst expectations of ~63% annual EPS growth and ~47% revenue growth in the latter half of the decade. The author favors Broadcom for scale and stability despite leverage, and flags Marvell as a higher-risk, higher-cyclicality “trap” if the AI buildout slows.

Analysis

Hyperscaler buying patterns will be the decisive second-order force here: when capex paces tighten, customers shift from price-insensitive, quota-driven purchases to aggressive vendor consolidation and longer RFQs. That favors a scaled supplier with software stickiness and multi-product bundling (Broadcom) over a hyperscaler-dependent, hardware-only vendor with concentrated revenue (Marvell). Additionally, foundry and optics chokepoints create asymmetric optionality — if node/optical scarcity persists, incumbents with privileged allocation or deeper OEM relationships can extract margin even without share gains.

The next 3–12 months are catalytic: quarterly guides from hyperscalers and inventory digests will reprice cyclicality faster than long-term model upgrades. Over 12–36 months, two structural reversals can flip the story — NVDA-led general-purpose acceleration that reduces bespoke ASIC demand, or a meaningful drop in rates that eases Broadcom’s debt servicing and reopens buybacks/M&A optionality. Tail risks include an AI pause causing >30% sequential capex cuts or an antitrust/FPF-style regulatory action that impairs Broadcom’s software bundling and de-rates its premium multiple.

Consensus is underestimating the convexity in downside for Marvell and the buried upside optionality in Broadcom’s balance-sheet flexibility if rates roll over. Pragmatically, this argues for asymmetric exposure: own Broadcom for durable cash-flow optionality while hedging the GDP-cyclical ASIC exposure that Marvell carries. The immediate tactical window is around next hyperscaler earnings and the next Fed repricing; that’s where gamma from options and pair trades will be most efficient for expressing this view.

Key Decisions for Investors

• Pair trade (3–9 months): Long AVGO shares 1.0x notional / Short MRVL shares 0.6x notional. R/R: target 20–35% relative return if AI spending normalizes; risk: 15–25% loss if MRVL re-rates or Broadcom faces a software shock. Place hard stop-loss on the pair at a 12% absolute move against the position.
• Option hedge (6–12 months): Buy AVGO 12–18 month call spread (buy ITM call, sell higher strike) sized to equal 50–75% of preferred equity exposure. R/R: caps downside to premium (~6–10% of capital) while capturing 25–40% upside in a prolonged AI cycle; mitigates Broadcom debt event exposure versus naked long.
• Speculative short (3–6 months): Short MRVL or buy MRVL 3–6 month put spread sized small (<=3% portfolio). R/R: captures volatility if hyperscaler guides slow; risk: limited to premium on put spreads, or unlimited if naked short — prefer spread structure.
• Convex protection (0–12 months): Buy a low-cost NVDA or AI-sector put spread as a macro hedge (protects pair trade in the event of an AI macro unwind). R/R: small drag in steady-state (1–3% premium) but mitigates correlated drawdowns if NVDA-led demand resets.
• Event-triggered liquidity play (days–weeks around earnings): If Broadcom reports softer guidance but reiterates buyback/balance-sheet priorities, scale into AVGO using a staggered ladder over 48 hours; if hyperscalers flag capex cuts, widen short MRVL exposure quickly and trim after the knee-jerk move (target 30–50% of intended position on day 1).